{"id":"NCT02247804","sponsor":"Allergan","briefTitle":"Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension","officialTitle":"The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-15","primaryCompletion":"2018-02-19","completion":"2019-07-19","firstPosted":"2014-09-25","resultsPosted":"2020-04-24","lastUpdate":"2020-06-11"},"enrollment":594,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Bimatoprost SR","otherNames":["AGN-192024"]},{"type":"DRUG","name":"Active Comparator: Timolol 0.5%","otherNames":[]},{"type":"OTHER","name":"Sham: Applicator Without Needle","otherNames":[]},{"type":"DRUG","name":"Timolol Vehicle (placebo)","otherNames":[]}],"arms":[{"label":"Bimatoprost SR 15 μg","type":"EXPERIMENTAL"},{"label":"Bimatoprost SR 10 μg","type":"EXPERIMENTAL"},{"label":"Timolol 0.5%","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the efficacy and safety of bimatoprost SR in participants with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.","primaryOutcome":{"measure":"Change From Baseline in IOP in the Study Eye at Week 12 (Hours 0 and 2)","timeFrame":"Baseline (Hours 0 and 2) to Week 12 (Hours 0 and 2)","effectByArm":[{"arm":"Bimatoprost SR 15 μg","deltaMin":-6.46,"sd":0.29},{"arm":"Bimatoprost SR 10 μg","deltaMin":-6.38,"sd":0.28},{"arm":"Timolol 0.5%: Comparator","deltaMin":-6.05,"sd":0.28}],"pValues":[{"comp":"OG000 vs OG002","p":"0.2950"},{"comp":"OG001 vs OG002","p":"0.3904"},{"comp":"OG000 vs OG002","p":"0.0464"},{"comp":"OG001 vs OG002","p":"0.5383"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":4},"locations":{"siteCount":106,"countries":["United States","Australia","Austria","Belgium","Brazil","Denmark","Hong Kong","Hungary","Israel","Peru","Philippines","Poland","Spain","Taiwan"]},"refs":{"pmids":["36378864","35643967"],"seeAlso":["http://www.allerganclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":193},"commonTop":["Conjunctival hyperaemia","Eye irritation","Foreign body sensation in eyes","Eye pain","Conjunctival haemorrhage"]}}